Showing results (411-420 of 542) with videos related to
Sort By:
Pageof 55
Atherosclerosis|February 1, 1996
Apo B-containing lipoprotein particles in poorly controlled insulin-dependent diabetesB Igau, S Lestavel, V Clavey, et al.Atherosclerosis|August 1, 1989
Lipoprotein composition changes induced by fenofibrate in dysbetalipoproteinemia type IIIS Lussier-Cacan, J M Bard, L Boulet, et al.Annals of Medicine|April 1, 1991
A phenocopy of type III dysbetalipoproteinemia occurring in a candidate family for a putative apo E receptor defectJ Davignon, J Dallongeville, G Roederer, et al.The Journal of Biological Chemistry|January 19, 1996
Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythmT Lemberger, R Saladin, M Vázquez, et al.Diabetologia|January 24, 2006
The effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patientsK Al Majali, M B Cooper, B Staels, et al.Journal of Molecular Endocrinology|April 10, 2004
The transcriptional regulating protein of 132 kDa (TReP-132) differentially influences steroidogenic pathways in human adrenal NCI-H295 cellsF Gizard, E Teissier, I Dufort, et al.European Journal of Immunology|November 11, 1999
Schistosoma mansoni schistosomula reduce E-selectin and VCAM-1 expression in TNF-alpha-stimulated lung microvascular endothelial cells by interfering with the NF-kappaB pathwayF Trottein, S Nutten, V Angeli, et al.The Biochemical Journal|November 1, 1989
Antipeptide antibody against the human low-density-lipoprotein receptor. Characterization and cross-reactivity with bovine lymphocytesG Agnani, C Delpierre, S Benhamamouch, et al.The American Journal of Clinical Nutrition|July 30, 1999
Influence of mental stress and circadian cycle on postprandial lipemiaC Le Fur, M Romon, P Lebel, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|June 30, 1995
Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery diseaseA Boullier, M Hamon, E Walters-Laporte, et al.Pageof 55